Prime Medicine ^Investors

Prime Medicine is a venture capital fund headquartered in Cambridge, Massachusetts, established in 2019 The firm specializes in investing in innovative biotechnology companies that focus on advancing genetic medicine With a significant investment scale of $175 million, Prime Medicine aims to support groundbreaking research and development in the field of gene editing and therapeutic solutions The fund is committed to fostering the growth of companies that have the potential to transform healthcare through cutting-edge technologies